|Bid||274.57 x 800|
|Ask||274.82 x 800|
|Day's range||271.21 - 276.38|
|52-week range||176.11 - 292.17|
|Beta (3Y monthly)||1.26|
|PE ratio (TTM)||59.45|
|Earnings date||30 Oct 2019 - 4 Nov 2019|
|Forward dividend & yield||N/A (N/A)|
|1y target est||291.67|
Idexx (IDXX) delivered earnings and revenue surprises of 4.38% and -1.25%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
With the U.S. pet industry poised to grow 3.9% to a record $75.4 billion this year, here are few stocks that could gain from the growing love for animals.
IDEXX (IDXX) consistently benefits from strong organic growth, driven by robust sales at the CAG business, fueled by a firm global Catalyst adoption.
IDEXX Laboratories is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.